Funding Opportunities

[ Limited Submissions | Intramural Awards | Foundations/Other | NIH ]

Intramural Funding Opportunities

For questions about intramural awards, please contact Meredith Donnelly.

• Deadline: Nov 21, 2025
  Benioff Initiative for Prostate Cancer Research Awards
  Through a generous philanthropic gift, the Benioff Initiative for Prostate Cancer Research is requesting applications for funding to support research aimed at improving outcomes for aggressive prostate cancer including the development of new therapies. Applications are welcome for projects in basic laboratory, computational, or translational research directly related to prostate cancer. 
• Deadline: Dec 1, 2025
  Computational Cancer Research RFA
  The Center for Cancer Data Science, a partnership between The Helen Diller Family Comprehensive Cancer Center and the Bakar Computational Health Sciences Institute, is requesting applications for projects in computational cancer research that harness data available in Information Commons/Cancer Commons.
• Deadline: Dec 1, 2025
  UCPCC Early Detection Award
  The UC Pancreatic Cancer Consortium (UCPCC) proposes to fund a two-year pilot project in a novel area of early detection for pancreatic cancer. Preference will be given to collaborations across two or more UC cancer centers although single principal investigators may apply.

Foundations/Other Sources

• Deadlines: Various dates through Feb 3, 2026
  Children's Tumor Foundation Discovery Fund Grants
  The Children’s Tumor Foundation has issued three RFAs in the field of neurofibromatosis (NF) and related disorders, including schwannomatosis: (1) Young Investigator Award; (2) Drug Discovery Initiative; (3) Clinical Research Award.
• Deadline: Nov 25, 2025
  NCCN Decision Making, Quality of Life, and Outcome Improvement Initiatives in Chronic Myeloid Leukemia (CML)
  This RFP invites investigators to develop and submit proposals for innovative decision making, quality of life (QOL), and outcome improvement projects to optimize the care of patients with CML.
• Deadline: Dec 1, 2025
  Cancer Research Institute Clinical Innovator
  This program funds innovative phase I/II or phase II clinical studies with a strong emphasis on: (1) novel immunotherapy approaches; (2) mechanistic investigations into clinical response; (3) the discovery and/or validation of predictive biomarkers.
• Deadline: Dec 2, 2025
  Damon Runyon Physician-Scientist Training Program
  This program was established to recruit outstanding U.S. Specialty Board eligible physicians into cancer research careers by providing them with the opportunity for a protected research training experience under the mentorship of a highly qualified and gifted mentor after they have completed all of their clinical training.
• Deadline: Dec 5, 2025
  AbbVie Independent Medical Education in Chronic Lymphocytic Leukemia (CLL)
  This program is seeking proposals that will review strategies for effective shared decision-making and highlight why shared decision-making is crucial in CLL treatment selection. UCSF applicants, please email [email protected] to announce your intention to apply.
• Deadline: Dec 15, 2025
  The Elsa U. Pardee Foundation Supporting Innovative Cancer Research
  The Elsa U. Pardee Foundation has issued a request for applications for cancer research grants. Proposed projects may be relevant to any area of cancer detection, treatment, or cure. Funding is intended to allow the establishment of capabilities of new cancer researchers or new cancer approaches by established cancer researchers, and lead to subsequent and expanded support using government agency funding.
• Deadline: Dec 18, 2025
  Breast Cancer Research Foundation-AACR NextGen Grant for Transformative Cancer Research
  This grant mechanism is intended to promote and support creative, paradigm-shifting cancer research that may not be funded through conventional channels. It is expected that these grants will catalyze significant scientific discoveries and help talented young investigators gain scientific independence. The proposed project may be basic, translational, clinical, or population-based research in nature and must have direct applicability and relevance to breast cancer.
• LOI Deadline: Jan 6, 2026
  PCORI Award: Partnering Research and Community Organizations for Comparative Clinical Effectiveness Research Across the Cancer Care Continuum
  Seeking to fund high-impact, patient-centered comparative clinical effectiveness research (CER) projects led by researcher and community partnerships to focus on advancing care and outcomes across different phases of the cancer care continuum.
• Deadline: Jan 9, 2026
  NCCN Lung Cancer Screening Quality Improvement Initiative
  National Comprehensive Cancer Network (NCCN) in collaboration with Merck Sharp & Dohme Corporation are offering a new funding opportunity in the area of lung cancer screening. Investigators are invited to develop and submit proposals outlining quality improvement and implementation science projects focused on improving the uptake of, and adherence to, lung cancer screening in people at high risk.

NIH Announcements

If you are a Cancer Center member who is interested in applying and receiving grant writing support, please contact Erin Bank.

• N/A

To view NCI funding opportunities, search here

In accordance with Federal and State law and University policy, the University of California does not discriminate on the basis of age, gender, race, ethnicity, national origin, religion, sexual orientation, gender identity, health, or disability. For detailed information, please visit the Office for the Prevention of Harassment and Discrimination.